{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:01:12Z","timestamp":1793797272339,"version":"4.6.1"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"8023","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2024,8,1]]},"DOI":"10.1038\/s41586-024-07530-w","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:04:41Z","timestamp":1722427481000},"page":"39-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":146,"title":["Sophisticated natural products as antibiotics"],"prefix":"10.1038","volume":"632","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1621-7664","authenticated-orcid":false,"given":"Kim","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2397-0443","authenticated-orcid":false,"given":"Richard E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-1832","authenticated-orcid":false,"given":"Heike","family":"Br\u00f6tz-Oesterhelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6709-4684","authenticated-orcid":false,"given":"Sebastian","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina V.","family":"Rodnina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7269-4716","authenticated-orcid":false,"given":"Tanja","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0831-8673","authenticated-orcid":false,"given":"Markus","family":"Weingarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Wohlgemuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"7530_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","volume":"181","author":"K Lewis","year":"2020","unstructured":"Lewis, K. The science of antibiotic discovery. Cell 181, 29\u201345 (2020).","journal-title":"Cell"},{"key":"7530_CR2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli, E. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318\u2013327 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"7530_CR3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators.","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655 (2022).","journal-title":"Lancet"},{"key":"7530_CR4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jinf.2018.02.007","volume":"76","author":"JA Ramos-Castaneda","year":"2018","unstructured":"Ramos-Castaneda, J. A. et al. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: systematic review and meta-analysis: mortality due to KPC Klebsiella pneumoniae infections. J. Infect. 76, 438\u2013448 (2018).","journal-title":"J. Infect."},{"key":"7530_CR5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu, L., Sun, X. & Ma, X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann. Clin. Microbiol. Antimicrob. 16, 18 (2017).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"7530_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.resmic.2018.02.002","volume":"169","author":"HI Zgurskaya","year":"2018","unstructured":"Zgurskaya, H. I., Rybenkov, V. V., Krishnamoorthy, G. & Leus, I. V. Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier. Res. Microbiol. 169, 351\u2013356 (2018).","journal-title":"Res. Microbiol."},{"key":"7530_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.mi.39.100185.001541","volume":"39","author":"JT Staley","year":"1985","unstructured":"Staley, J. T. & Konopka, A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu. Rev. Microbiol. 39, 321\u2013346 (1985).","journal-title":"Annu. Rev. Microbiol."},{"key":"7530_CR8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.chembiol.2010.02.010","volume":"17","author":"A D\u2019Onofrio","year":"2010","unstructured":"D\u2019Onofrio, A. et al. Siderophores from neighboring organisms promote the growth of uncultured bacteria. Chem. Biol. 17, 254\u2013264 (2010).","journal-title":"Chem. Biol."},{"key":"7530_CR9","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-017-0380-5","volume":"5","author":"K Fenn","year":"2017","unstructured":"Fenn, K. et al. Quinones are growth factors for the human gut microbiota. Microbiome 5, 161 (2017).","journal-title":"Microbiome"},{"key":"7530_CR10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41564-018-0307-3","volume":"4","author":"P Strandwitz","year":"2019","unstructured":"Strandwitz, P. et al. GABA-modulating bacteria of the human gut microbiota. Nat. Microbiol. 4, 396\u2013403 (2019).","journal-title":"Nat. Microbiol."},{"key":"7530_CR11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"LL Ling","year":"2015","unstructured":"Ling, L. L. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455\u2013459 (2015). This paper describes the discovery of teixobactin from an uncultured bacterium.","journal-title":"Nature"},{"key":"7530_CR12","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.cell.2023.07.038","volume":"186","author":"R Shukla","year":"2023","unstructured":"Shukla, R. et al. An antibiotic from an uncultured bacterium binds to an immutable target. Cell 186, 4059\u20134073.e4027 (2023).","journal-title":"Cell"},{"key":"7530_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molcel.2018.03.001","volume":"70","author":"L Pantel","year":"2018","unstructured":"Pantel, L. et al. Odilorhabdins, antibacterial agents that cause miscoding by binding at a new ribosomal site. Mol. Cell 70, 83\u201394 e87 (2018).","journal-title":"Mol. Cell"},{"key":"7530_CR14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-019-1791-1","volume":"576","author":"Y Imai","year":"2019","unstructured":"Imai, Y. et al. A new antibiotic selectively kills Gram-negative pathogens. Nature 576, 459\u2013464 (2019).","journal-title":"Nature"},{"key":"7530_CR15","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41589-022-01102-7","volume":"18","author":"Y Imai","year":"2022","unstructured":"Imai, Y. et al. Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis. Nat. Chem. Biol. 18, 1236\u20131244 (2022). This paper describes the discovery of darobactins that target BamA in the outer membrane of Gram-negative bacteria.","journal-title":"Nat. Chem. Biol."},{"key":"7530_CR16","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41564-022-01227-4","volume":"7","author":"RD Miller","year":"2022","unstructured":"Miller, R. D. et al. Computational identification of a systemic antibiotic for gram-negative bacteria. Nat. Microbiol. 7, 1661\u20131672 (2022).","journal-title":"Nat. Microbiol."},{"key":"7530_CR17","doi-asserted-by":"crossref","first-page":"e0070022","DOI":"10.1128\/mbio.00700-22","volume":"13","author":"N Shahsavari","year":"2022","unstructured":"Shahsavari, N. et al. A silent operon of Photorhabdus luminescens encodes a prodrug mimic of GTP. mBio 13, e0070022 (2022).","journal-title":"mBio"},{"key":"7530_CR18","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32858-0","volume":"13","author":"V Libis","year":"2022","unstructured":"Libis, V. et al. Multiplexed mobilization and expression of biosynthetic gene clusters. Nat. Commun. 13, 5256 (2022). This paper describes an approach for efficient cloning of environmental DNA for the expression of BGCs.","journal-title":"Nat. Commun."},{"key":"7530_CR19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41564-022-01110-2","volume":"7","author":"A Gavriilidou","year":"2022","unstructured":"Gavriilidou, A. et al. Compendium of specialized metabolite biosynthetic diversity encoded in bacterial genomes. Nat. Microbiol. 7, 726\u2013735 (2022). This study catalogues BGCs from sequenced genomes and links them to taxonomy and biogeography.","journal-title":"Nat. Microbiol."},{"key":"7530_CR20","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/jm700967e","volume":"51","author":"R O\u2019Shea","year":"2008","unstructured":"O\u2019Shea, R. & Moser, H. E. Physicochemical properties of antibacterial compounds: Implications for drug discovery. J. Med. Chem. 51, 2871\u20132878 (2008).","journal-title":"J. Med. Chem."},{"key":"7530_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nature22308","volume":"545","author":"MF Richter","year":"2017","unstructured":"Richter, M. F. et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 545, 299\u2013304 (2017). This study provides rules for compound penetration into Gram-negative bacteria.","journal-title":"Nature"},{"key":"7530_CR22","doi-asserted-by":"crossref","first-page":"e02785","DOI":"10.1128\/mBio.02785-20","volume":"12","author":"J Mehla","year":"2021","unstructured":"Mehla, J. et al. Predictive rules of efflux inhibition and avoidance in Pseudomonas aeruginosa. mBio 12, e02785\u201320 (2021). This study analyses physico-chemical properties of compounds that enable penetration into P. aeruginosa, and synthesis of MDR inhibitors.","journal-title":"mBio"},{"key":"7530_CR23","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41589-020-00674-6","volume":"16","author":"S Zhao","year":"2020","unstructured":"Zhao, S. et al. Defining new chemical space for drug penetration into Gram-negative bacteria. Nat. Chem. Biol. 16, 1293\u20131302 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"7530_CR24","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1021\/acs.jcim.0c00352","volume":"60","author":"RA Mansbach","year":"2020","unstructured":"Mansbach, R. A. et al. Machine learning algorithm identifies an antibiotic vocabulary for permeating Gram-negative bacteria. J. Chem. Inf. Model. 60, 2838\u20132847 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"7530_CR25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-023-06760-8","volume":"624","author":"EJ Geddes","year":"2023","unstructured":"Geddes, E. J. et al. Porin-independent accumulation in Pseudomonas enables antibiotic discovery. Nature 624, 145\u2013153 (2023).","journal-title":"Nature"},{"key":"7530_CR26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41564-019-0604-5","volume":"5","author":"EN Parker","year":"2020","unstructured":"Parker, E. N. et al. Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogens. Nat. Microbiol. 5, 67\u201375 (2020).","journal-title":"Nat. Microbiol."},{"key":"7530_CR27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41586-021-03899-0","volume":"597","author":"TF Durand-Reville","year":"2021","unstructured":"Durand-Reville, T. F. et al. Rational design of a new antibiotic class for drug-resistant infections. Nature 597, 698\u2013702 (2021).","journal-title":"Nature"},{"key":"7530_CR28","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1182749","volume":"327","author":"N Srinivas","year":"2010","unstructured":"Srinivas, N. et al. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327, 1010\u20131013 (2010).","journal-title":"Science"},{"key":"7530_CR29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41586-019-1665-6","volume":"576","author":"A Luther","year":"2019","unstructured":"Luther, A. et al. Chimeric peptidomimetic antibiotics against Gram-negative bacteria. Nature 576, 452\u2013458 (2019).","journal-title":"Nature"},{"key":"7530_CR30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-023-06799-7","volume":"625","author":"KS Pahil","year":"2024","unstructured":"Pahil, K. S. et al. A new antibiotic traps lipopolysaccharide in its intermembrane transporter. Nature 625, 572\u2013577 (2024).","journal-title":"Nature"},{"key":"7530_CR31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-023-06873-0","volume":"625","author":"C Zampaloni","year":"2024","unstructured":"Zampaloni, C. et al. A novel antibiotic class targeting the lipopolysaccharide transporter. Nature 625, 566\u2013571 (2024).","journal-title":"Nature"},{"key":"7530_CR32","first-page":"226","volume":"10","author":"A Fleming","year":"1929","unstructured":"Fleming, A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Br. J. Exp. Pathol. 10, 226 (1929).","journal-title":"Br. J. Exp. Pathol."},{"key":"7530_CR33","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1039\/D1MD00200G","volume":"12","author":"M Mora-Ochomogo","year":"2021","unstructured":"Mora-Ochomogo, M. & Lohans, C. T. \u03b2-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates. RSC Med. Chem. 12, 1623\u20131639 (2021).","journal-title":"RSC Med. Chem."},{"key":"7530_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2202","volume":"6","author":"LL Silver","year":"2007","unstructured":"Silver, L. L. Multi-targeting by monotherapeutic antibacterials. Nat. Rev. Drug Discov. 6, 41\u201355 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"7530_CR35","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.11.5.852","volume":"11","author":"C Reading","year":"1977","unstructured":"Reading, C. & Cole, M. Clavulanic acid: a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 11, 852\u2013857 (1977).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7530_CR36","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1128\/AAC.03579-14","volume":"58","author":"P Levasseur","year":"2014","unstructured":"Levasseur, P. et al. Efficacy of a ceftazidime\u2013avibactam combination in a murine model of septicemia caused by Enterobacteriaceae species producing ampc or extended-spectrum \u03b2-lactamases. Antimicrob. Agents Chemother. 58, 6490\u20136495 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7530_CR37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40121-018-0214-1","volume":"7","author":"RG Wunderink","year":"2018","unstructured":"Wunderink, R. G. et al. Effect and safety of meropenem-vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: The TANGO II randomized clinical trial. Infect. Dis. Ther. 7, 439\u2013455 (2018).","journal-title":"Infect. Dis. Ther."},{"key":"7530_CR38","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/nbt1206-1504","volume":"24","author":"K Lewis","year":"2006","unstructured":"Lewis, K. & Ausubel, F. M. Prospects for plant-derived antibacterials. Nat. Biotechnol. 24, 1504\u20131507 (2006).","journal-title":"Nat. Biotechnol."},{"key":"7530_CR39","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.030540597","volume":"97","author":"FR Stermitz","year":"2000","unstructured":"Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A. & Lewis, K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5\u2032-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl Acad. Sci. USA 97, 1433\u20131437 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7530_CR40","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/acsinfecdis.2c00263","volume":"8","author":"M Moniruzzaman","year":"2022","unstructured":"Moniruzzaman, M. et al. Analysis of orthogonal efflux and permeation properties of compounds leads to the discovery of new efflux pump inhibitors. ACS Infect. Dis. 8, 2149\u20132160 (2022).","journal-title":"ACS Infect. Dis."},{"key":"7530_CR41","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/gutjnl-2018-317503","volume":"68","author":"MG Dominguez-Bello","year":"2019","unstructured":"Dominguez-Bello, M. G., Godoy-Vitorino, F., Knight, R. & Blaser, M. J. Role of the microbiome in human development. Gut 68, 1108\u20131114 (2019).","journal-title":"Gut"},{"key":"7530_CR42","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41575-022-00610-0","volume":"19","author":"MK Schnizlein","year":"2022","unstructured":"Schnizlein, M. K. & Young, V. B. Capturing the environment of the Clostridioides difficile infection cycle. Nat. Rev. Gastroenterol. Hepatol. 19, 508\u2013520 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7530_CR43","doi-asserted-by":"crossref","first-page":"110649","DOI":"10.1016\/j.celrep.2022.110649","volume":"39","author":"WE Anthony","year":"2022","unstructured":"Anthony, W. E. et al. Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults. Cell Rep. 39, 110649 (2022).","journal-title":"Cell Rep."},{"key":"7530_CR44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa2106516","volume":"386","author":"P Feuerstadt","year":"2022","unstructured":"Feuerstadt, P. et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N. Engl. J. Med. 386, 220\u2013229 (2022). This paper describes the introduction of a new type of \u2018drug\u2019\u2014an assemblage of clostridial spores for the treatment of C. difficile infection.","journal-title":"N. Engl. J. Med."},{"key":"7530_CR45","doi-asserted-by":"crossref","DOI":"10.1186\/1757-4749-5-23","volume":"5","author":"LR Lopetuso","year":"2013","unstructured":"Lopetuso, L. R., Scaldaferri, F., Petito, V. & Gasbarrini, A. Commensal clostridia: leading players in the maintenance of gut homeostasis. Gut Pathog. 5, 23 (2013).","journal-title":"Gut Pathog."},{"key":"7530_CR46","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/AAC.39.11.2484","volume":"39","author":"K Mikusova","year":"1995","unstructured":"Mikusova, K., Slayden, R. A., Besra, G. S. & Brennan, P. J. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob. Agents Chemother. 39, 2484\u20132489 (1995).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7530_CR47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1060028013504087","volume":"48","author":"EB Chahine","year":"2014","unstructured":"Chahine, E. B., Karaoui, L. R. & Mansour, H. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Ann. Pharmacother. 48, 107\u2013115 (2014).","journal-title":"Ann. Pharmacother."},{"key":"7530_CR48","doi-asserted-by":"crossref","first-page":"673100","DOI":"10.3389\/fcimb.2021.673100","volume":"11","author":"D Diallo","year":"2021","unstructured":"Diallo, D. et al. Antituberculosis therapy and gut microbiota: review of potential host microbiota directed-therapies. Front. Cell. Infect. Microbiol. 11, 673100 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"7530_CR49","doi-asserted-by":"crossref","first-page":"e01516","DOI":"10.1128\/mBio.01516-20","volume":"11","author":"J Quigley","year":"2020","unstructured":"Quigley, J. et al. Novel antimicrobials from uncultured bacteria acting against Mycobacterium tuberculosis. mBio 11, e01516\u2013e01520 (2020).","journal-title":"mBio"},{"key":"7530_CR50","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/antibiotics11091218","volume":"11","author":"T Motiwala","year":"2022","unstructured":"Motiwala, T., Mthethwa, Q., Achilonu, I. & Khoza, T. ESKAPE pathogens: looking at Clp ATPases as potential drug targets. Antibiotics 11, 1218 (2022).","journal-title":"Antibiotics"},{"key":"7530_CR51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41586-020-2072-8","volume":"580","author":"S Rempel","year":"2020","unstructured":"Rempel, S. et al. A mycobacterial ABC transporter mediates the uptake of hydrophilic compounds. Nature 580, 409\u2013412 (2020).","journal-title":"Nature"},{"key":"7530_CR52","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1016\/j.cell.2021.09.011","volume":"184","author":"N Leimer","year":"2021","unstructured":"Leimer, N. et al. A selective antibiotic for Lyme disease. Cell 184, 5405\u20135418.e5416 (2021). This paper describes the identification of an antibiotic for selective action against B. burgdorferi.","journal-title":"Cell"},{"key":"7530_CR53","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nsmb.2992","volume":"22","author":"YS Polikanov","year":"2015","unstructured":"Polikanov, Y. S., Melnikov, S. V., Soll, D. & Steitz, T. A. Structural insights into the role of rRNA modifications in protein synthesis and ribosome assembly. Nat. Struct. Mol. Biol. 22, 342\u2013344 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"7530_CR54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0006-291X(66)90188-4","volume":"24","author":"AN Chatterjee","year":"1966","unstructured":"Chatterjee, A. N. & Perkins, H. R. Compounds formed between nucleotides related to the biosynthesis of bacterial cell wall and vancomycin. Biochem. Biophys. Res. Commun. 24, 489\u2013494 (1966).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"7530_CR55","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1016\/j.bbamem.2015.04.014","volume":"1848","author":"D Munch","year":"2015","unstructured":"Munch, D. & Sahl, H. G. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides. Biochim. Biophys. Acta 1848, 3062\u20133071 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"7530_CR56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","volume":"319","author":"R Leclercq","year":"1988","unstructured":"Leclercq, R., Derlot, E., Duval, J. & Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319, 157\u2013161 (1988).","journal-title":"N. Engl. J. Med."},{"key":"7530_CR57","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.94.12.6480","volume":"94","author":"CG Marshall","year":"1997","unstructured":"Marshall, C. G., Broadhead, G., Leskiw, B. K. & Wright, G. D. d-Ala\u2013d-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc. Natl Acad. Sci. USA 94, 6480\u20136483 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7530_CR58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41586-022-05019-y","volume":"608","author":"R Shukla","year":"2022","unstructured":"Shukla, R. et al. Teixobactin kills bacteria by a two-pronged attack on the cell envelope. Nature 608, 390\u2013396 (2022).","journal-title":"Nature"},{"key":"7530_CR59","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.cell.2023.07.038","volume":"186","author":"R Shukla","year":"2023","unstructured":"Shukla, R. et al. An antibiotic from an uncultured bacterium binds to an immutable target. Cell 186, 4059\u20134073 (2023).","journal-title":"Cell"},{"key":"7530_CR60","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1128\/AAC.01050-16","volume":"60","author":"T Homma","year":"2016","unstructured":"Homma, T. et al. Dual targeting of cell wall precursors by teixobactin leads to cell lysis. Antimicrob. Agents Chemother. 60, 6510\u20136517 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7530_CR61","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3181\/00379727-55-14461","volume":"55","author":"A Schatz","year":"1944","unstructured":"Schatz, A., Bugie, E. & Waksman, S. A. Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. Proc. Soc. Exp. Biol. Med. 55, 66\u201369 (1944).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"7530_CR62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrmicro3155","volume":"12","author":"DN Wilson","year":"2014","unstructured":"Wilson, D. N. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat. Rev. Microbiol. 12, 35\u201348 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"7530_CR63","doi-asserted-by":"crossref","first-page":"e2013315118","DOI":"10.1073\/pnas.2013315118","volume":"118","author":"J Aguirre Rivera","year":"2021","unstructured":"Aguirre Rivera, J. et al. Real-time measurements of aminoglycoside effects on protein synthesis in live cells. Proc. Natl Acad. Sci. USA 118, e2013315118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7530_CR64","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00332630","volume":"187","author":"DI Andersson","year":"1982","unstructured":"Andersson, D. I., Bohman, K., Isaksson, L. A. & Kurland, C. G. Translation rates and misreading characteristics of rpsD mutants in Escherichia coli. Mol. Genetics Genomics 187, 467\u2013472 (1982).","journal-title":"Mol. Genetics Genomics"},{"key":"7530_CR65","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21942-6","volume":"12","author":"I Wohlgemuth","year":"2021","unstructured":"Wohlgemuth, I. et al. Translation error clusters induced by aminoglycoside antibiotics. Nat. Commun. 12, 1830 (2021). This study reveals the basis of killing by aminoglycosides\u2014the introduction of strings of errors into nascent proteins.","journal-title":"Nat. Commun."},{"key":"7530_CR66","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.sbi.2009.08.003","volume":"19","author":"N Tokuriki","year":"2009","unstructured":"Tokuriki, N. & Tawfik, D. S. Stability effects of mutations and protein evolvability. Curr. Opin. Struct. Biol. 19, 596\u2013604 (2009).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"7530_CR67","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.aaa4690","volume":"348","author":"A Kling","year":"2015","unstructured":"Kling, A. et al. Targeting DnaN for tuberculosis therapy using novel griselimycins. Science 348, 1106\u20131112 (2015).","journal-title":"Science"},{"key":"7530_CR68","doi-asserted-by":"crossref","unstructured":"Lewis, K. (ed.) Persister Cells and Infectious Disease (Springer Nature, 2019).","DOI":"10.1007\/978-3-030-25241-0"},{"key":"7530_CR69","doi-asserted-by":"crossref","first-page":"e1000317","DOI":"10.1371\/journal.pbio.1000317","volume":"8","author":"T. Dorr","year":"2010","unstructured":"Dorr, T., Vulic, M. & Lewis, K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8, e1000317 (2010).","journal-title":"PLoS Biol."},{"key":"7530_CR70","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/mmi.13607","volume":"103","author":"BA Berghoff","year":"2017","unstructured":"Berghoff, B. A., Hoekzema, M., Aulbach, L. & Wagner, E. G. Two regulatory RNA elements affect TisB-dependent depolarization and persister formation. Mol. Microbiol. 103, 1020\u20131033 (2017).","journal-title":"Mol. Microbiol."},{"key":"7530_CR71","doi-asserted-by":"crossref","first-page":"15901","DOI":"10.1073\/pnas.1904309116","volume":"116","author":"C Romilly","year":"2019","unstructured":"Romilly, C., Deindl, S. & Wagner, E. G. H. The ribosomal protein S1-dependent standby site in tisB mRNA consists of a single-stranded region and a 5\u2032 structure element. Proc. Natl Acad. Sci. USA 116, 15901\u201315906 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7530_CR72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature14662","volume":"524","author":"MA Schumacher","year":"2015","unstructured":"Schumacher, M. A. et al. HipBA\u2013promoter structures reveal the basis of heritable multidrug tolerance. Nature 524, 59\u201364 (2015).","journal-title":"Nature"},{"key":"7530_CR73","doi-asserted-by":"crossref","first-page":"e3001194","DOI":"10.1371\/journal.pbio.3001194","volume":"19","author":"S Manuse","year":"2021","unstructured":"Manuse, S. et al. Bacterial persisters are a stochastically formed subpopulation of low-energy cells. PLoS Biol. 19, e3001194 (2021).","journal-title":"PLoS Biol."},{"key":"7530_CR74","doi-asserted-by":"crossref","first-page":"e0294822","DOI":"10.1128\/spectrum.02948-22","volume":"10","author":"J Quigley","year":"2022","unstructured":"Quigley, J. & Lewis, K. Noise in a metabolic pathway leads to persister formation in Mycobacterium tuberculosis. Microbiol. Spectr. 10, e0294822 (2022).","journal-title":"Microbiol. Spectr."},{"key":"7530_CR75","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1128\/AAC.02136-13","volume":"58","author":"LE Fleck","year":"2014","unstructured":"Fleck, L. E. et al. A screen for and validation of prodrug antimicrobials. Antimicrob. Agents Chemother. 58, 1410\u20131419 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7530_CR76","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1021\/np500158q","volume":"77","author":"JD Goodreid","year":"2014","unstructured":"Goodreid, J. D. et al. Total synthesis and antibacterial testing of the A54556 cyclic acyldepsipeptides isolated from Streptomyces hawaiiensis. J. Nat. Prod. 77, 2170\u20132181 (2014).","journal-title":"J. Nat. Prod."},{"key":"7530_CR77","doi-asserted-by":"crossref","first-page":"e01292","DOI":"10.1128\/AEM.01292-19","volume":"85","author":"D Thomy","year":"2019","unstructured":"Thomy, D. et al. The ADEP biosynthetic gene cluster in Streptomyces hawaiiensis NRRL 15010 reveals an accessory clpP gene as a novel antibiotic resistance factor. Appl. Environ. Microbiol. 85, e01292\u201319 (2019).","journal-title":"Appl. Environ. Microbiol."},{"key":"7530_CR78","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/nm1306","volume":"11","author":"H Brotz-Oesterhelt","year":"2005","unstructured":"Brotz-Oesterhelt, H. et al. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat. Med. 11, 1082\u20131087 (2005). This paper describes the discovery of the mechanism of killing by ADEP: dysregulation of the bacterial protease ClpP.","journal-title":"Nat. Med."},{"key":"7530_CR79","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nsmb.2885","volume":"21","author":"AO Olivares","year":"2014","unstructured":"Olivares, A. O., Nager, A. R., Iosefson, O., Sauer, R. T. & Baker, T. A. Mechanochemical basis of protein degradation by a double-ring AAA+ machine. Nat. Struct. Mol. Biol. 21, 871\u2013875 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"7530_CR80","doi-asserted-by":"crossref","first-page":"E6447","DOI":"10.1073\/pnas.1805125115","volume":"115","author":"S Vahidi","year":"2018","unstructured":"Vahidi, S. et al. Reversible inhibition of the ClpP protease via an N-terminal conformational switch. Proc. Natl Acad. Sci. USA 115, E6447\u2013E6456 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7530_CR81","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1021\/acsinfecdis.9b00245","volume":"5","author":"EC Griffith","year":"2019","unstructured":"Griffith, E. C. et al. Ureadepsipeptides as ClpP Activators. ACS Infect. Dis. 5, 1915\u20131925 (2019).","journal-title":"ACS Infect. Dis."},{"key":"7530_CR82","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/cbic.201900787","volume":"21","author":"IT Malik","year":"2020","unstructured":"Malik, I. T. et al. Functional characterisation of ClpP mutations conferring resistance to acyldepsipeptide antibiotics in firmicutes. ChemBioChem 21, 1997\u20132012 (2020).","journal-title":"ChemBioChem"},{"key":"7530_CR83","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41594-019-0304-0","volume":"26","author":"C Gatsogiannis","year":"2019","unstructured":"Gatsogiannis, C., Balogh, D., Merino, F., Sieber, S. A. & Raunser, S. Cryo-EM structure of the ClpXP protein degradation machinery. Nat. Struct. Mol. Biol. 26, 946\u2013954 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"7530_CR84","doi-asserted-by":"crossref","first-page":"e52158","DOI":"10.7554\/eLife.52158","volume":"9","author":"ZA Ripstein","year":"2020","unstructured":"Ripstein, Z. A., Vahidi, S., Houry, W. A., Rubinstein, J. L. & Kay, L. E. A processive rotary mechanism couples substrate unfolding and proteolysis in the ClpXP degradation machinery. eLife 9, e52158 (2020).","journal-title":"eLife"},{"key":"7530_CR85","doi-asserted-by":"crossref","first-page":"e52774","DOI":"10.7554\/eLife.52774","volume":"9","author":"X Fei","year":"2020","unstructured":"Fei, X. et al. Structures of the ATP-fueled ClpXP proteolytic machine bound to protein substrate. eLife 9, e52774 (2020).","journal-title":"eLife"},{"key":"7530_CR86","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1073\/pnas.1110385108","volume":"108","author":"P Sass","year":"2011","unstructured":"Sass, P. et al. Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ. Proc. Natl Acad. Sci. USA 108, 17474\u201317479 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7530_CR87","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s42003-021-01789-9","volume":"4","author":"N Silber","year":"2021","unstructured":"Silber, N., Mayer, C., Matos de Opitz, C. L. & Sass, P. Progression of the late-stage divisome is unaffected by the depletion of the cytoplasmic FtsZ pool. Commun. Biol. 4, 270 (2021).","journal-title":"Commun. Biol."},{"key":"7530_CR88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature12790","volume":"503","author":"BP Conlon","year":"2013","unstructured":"Conlon, B. P. et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503, 365\u2013370 (2013). This paper describes the anti-persister activity of ADEP.","journal-title":"Nature"},{"key":"7530_CR89","doi-asserted-by":"crossref","first-page":"e01554-19","DOI":"10.1128\/AAC.01554-19","volume":"64","author":"N Mroue","year":"2019","unstructured":"Mroue, N. et al. Pharmacodynamics of ClpP-activating antibiotic combinations against Gram-positive pathogens. Antimicrob. Agents Chemother. 64, e01554-19 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7530_CR90","doi-asserted-by":"crossref","first-page":"e00424-18","DOI":"10.1128\/AAC.00424-18","volume":"62","author":"A Brown Gandt","year":"2018","unstructured":"Brown Gandt, A. et al. In vivo and in vitro effects of a ClpP-activating antibiotic against vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 62, e00424-18 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7530_CR91","doi-asserted-by":"crossref","first-page":"690902","DOI":"10.3389\/fmolb.2021.690902","volume":"8","author":"H Brotz-Oesterhelt","year":"2021","unstructured":"Brotz-Oesterhelt, H. & Vorbach, A. Reprogramming of the caseinolytic protease by ADEP antibiotics: molecular mechanism, cellular consequences, therapeutic potential. Front. Mol. Biosci. 8, 690902 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"7530_CR92","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijmm.2013.11.009","volume":"304","author":"D Frees","year":"2014","unstructured":"Frees, D., Gerth, U. & Ingmer, H. Clp chaperones and proteases are central in stress survival, virulence and antibiotic resistance of Staphylococcus aureus. Int. J. Med. Microbiol. 304, 142\u2013149 (2014).","journal-title":"Int. J. Med. Microbiol."},{"key":"7530_CR93","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000517718","volume":"31","author":"A Illigmann","year":"2021","unstructured":"Illigmann, A., Thoma, Y., Pan, S., Reinhardt, L. & Brotz-Oesterhelt, H. Contribution of the Clp protease to bacterial survival and mitochondrial homoeostasis. Microb. Physiol. 31, 260\u2013279 (2021).","journal-title":"Microb. Physiol."},{"key":"7530_CR94","doi-asserted-by":"crossref","unstructured":"Schuster, M. et al. Peptidomimetic antibiotics disrupt the lipopolysaccharide transport bridge of drug-resistant Enterobacteriaceae. Sci. Adv. 9, eadg3683 (2023).","DOI":"10.1126\/sciadv.adg3683"},{"key":"7530_CR95","doi-asserted-by":"crossref","first-page":"18876","DOI":"10.1021\/jacs.2c05565","volume":"144","author":"H Nguyen","year":"2022","unstructured":"Nguyen, H. et al. Characterization of a radical SAM oxygenase for the ether crosslinking in darobactin biosynthesis. J. Am. Chem. Soc. 144, 18876\u201318886 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"7530_CR96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-021-03455-w","volume":"593","author":"H Kaur","year":"2021","unstructured":"Kaur, H. et al. The antibiotic darobactin mimics a \u03b2-strand to inhibit outer membrane insertase. Nature 593, 125\u2013129 (2021).","journal-title":"Nature"},{"key":"7530_CR97","doi-asserted-by":"crossref","first-page":"11882","DOI":"10.1039\/D1SC02725E","volume":"12","author":"S Gro\u00df","year":"2021","unstructured":"Gro\u00df, S. et al. Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering. Chem. Sci. 12, 11882\u201311893 (2021).","journal-title":"Chem. Sci."},{"key":"7530_CR98","doi-asserted-by":"crossref","first-page":"e202214094","DOI":"10.1002\/anie.202214094","volume":"62","author":"CE Seyfert","year":"2022","unstructured":"Seyfert, C. E. et al. Darobactins exhibiting superior antibiotic activity by Cryo-EM structure guided biosynthetic engineering. Angew. Chem. Int. Ed. Engl. 62, e202214094 (2022).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"7530_CR99","doi-asserted-by":"crossref","first-page":"14458","DOI":"10.1021\/jacs.2c05892","volume":"144","author":"YC Lin","year":"2022","unstructured":"Lin, Y. C. et al. Atroposelective total synthesis of darobactin A. J. Am. Chem. Soc. 144, 14458\u201314462 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"7530_CR100","doi-asserted-by":"crossref","first-page":"14026","DOI":"10.1021\/jacs.2c05891","volume":"144","author":"M Nesic","year":"2022","unstructured":"Nesic, M. et al. Total synthesis of darobactin A. J. Am. Chem. Soc. 144, 14026\u201314030 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"7530_CR101","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.drudis.2016.06.012","volume":"21","author":"YS Tan","year":"2016","unstructured":"Tan, Y. S., Lane, D. P. & Verma, C. S. Stapled peptide design: principles and roles of computation. Drug Discov. Today 21, 1642\u20131653 (2016).","journal-title":"Drug Discov. Today"},{"key":"7530_CR102","first-page":"182","volume":"6","author":"K Maeda","year":"1953","unstructured":"Maeda, K., Osato, T. & Umezawa, H. A new antibiotic, azomycin. J. Antibiot. 6, 182 (1953).","journal-title":"J. Antibiot."},{"key":"7530_CR103","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1248\/cpb1953.3.379","volume":"3","author":"S Nakamura","year":"1955","unstructured":"Nakamura, S. Structure of azomycin, a new antibiotic. Pharm. Bull. 3, 379\u2013383 (1955).","journal-title":"Pharm. Bull."},{"key":"7530_CR104","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.7164\/antibiotics.42.1513","volume":"42","author":"JH Shoji","year":"1989","unstructured":"Shoji, J. H. et al. Isolation of azomycin from Pseudomonas fluorescens. J. Antibiot. 42, 1513\u20131514 (1989).","journal-title":"J. Antibiot."},{"key":"7530_CR105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/ph15050561","volume":"15","author":"R Gupta","year":"2022","unstructured":"Gupta, R. et al. Functionalized nitroimidazole scaffold construction and their pharmaceutical applications: a 1950\u20132021 comprehensive overview. Pharmaceuticals 15, 561 (2022).","journal-title":"Pharmaceuticals"},{"key":"7530_CR106","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1099\/00221287-100-2-283","volume":"100","author":"BP Goldstein","year":"1977","unstructured":"Goldstein, B. P. et al. The mechanism of action of nitro-heterocyclic antimicrobial drugs. Metabolic activation by micro-organisms. J. Gen. Microbiol. 100, 283\u2013298 (1977).","journal-title":"J. Gen. Microbiol."},{"key":"7530_CR107","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/acs.accounts.1c00004","volume":"54","author":"MJ Miller","year":"2021","unstructured":"Miller, M. J. & Liu, R. Design and syntheses of new antibiotics inspired by nature\u2019s quest for iron in an oxidative climate. Acc. Chem. Res. 54, 1646\u20131661 (2021).","journal-title":"Acc. Chem. Res."},{"key":"7530_CR108","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1093\/cid\/ciz826","volume":"69","author":"T Sato","year":"2019","unstructured":"Sato, T. & Yamawaki, K. Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin. Clin. Infect. Dis. 69, S538\u2013S543 (2019). This paper describes the creation of an approved chimeric antibiotic utilizing a siderophore moiety for penetration into the cell.","journal-title":"Clin. Infect. Dis."},{"key":"7530_CR109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.10.002","volume":"85","author":"S Broder","year":"2010","unstructured":"Broder, S. The development of antiretroviral therapy and its impact on the HIV-1\/AIDS pandemic. Antiviral Res. 85, 1\u201318 (2010).","journal-title":"Antiviral Res."},{"key":"7530_CR110","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","volume":"74","author":"F Sanger","year":"1977","unstructured":"Sanger, F., Nicklen, S. & Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA 74, 5463\u20135467 (1977).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7530_CR111","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm.2015","volume":"15","author":"S Wu","year":"2009","unstructured":"Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016\u20131022 (2009).","journal-title":"Nat. Med."},{"key":"7530_CR112","doi-asserted-by":"crossref","first-page":"eabm3233","DOI":"10.1126\/science.abm3233","volume":"378","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites. Science 378, eabm3233 (2022).","journal-title":"Science"},{"key":"7530_CR113","doi-asserted-by":"crossref","first-page":"eabp9960","DOI":"10.1126\/science.abp9960","volume":"377","author":"JY Lee","year":"2022","unstructured":"Lee, J. Y., Tsolis, R. M. & Baumler, A. J. The microbiome and gut homeostasis. Science 377, eabp9960 (2022).","journal-title":"Science"},{"key":"7530_CR114","doi-asserted-by":"crossref","first-page":"eabo7793","DOI":"10.1126\/scitranslmed.abo7793","volume":"14","author":"MA Cook","year":"2022","unstructured":"Cook, M. A. & Wright, G. D. The past, present, and future of antibiotics. Sci. Transl. Med. 14, eabo7793 (2022).","journal-title":"Sci. Transl. Med."},{"key":"7530_CR115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-018-0483-6","volume":"561","author":"PA Smith","year":"2018","unstructured":"Smith, P. A. et al. Optimized arylomycins are a new class of Gram-negative antibiotics. Nature 561, 189\u2013194 (2018).","journal-title":"Nature"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07530-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07530-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07530-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:13:25Z","timestamp":1722428005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-07530-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":115,"journal-issue":{"issue":"8023","published-print":{"date-parts":[[2024,8,1]]}},"alternative-id":["7530"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-07530-w","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"28 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.L. is a consultant for NovoBiotic, Arietis, Odyssey Therapeutics, Holobiome, Donum and Flightpath. R.E.L. is an advisor for Prokaryotics and is a co-inventor of relevant intellectual property licensed by Arietis and Microbiotix. H.B.O. S.H., M.V.R., T.S., M.W. and I.W. declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}